Immuneering CorporationIMRXNASDAQ

52-Week Range1-10

1.10Current 5.0210.08

Want to monitor IMRX?

Get notified when price crosses targets, volume spikes, or RSI hits oversold

No description available.

Professional, Scientific, and Technical Services

Research and Development in Biotechnology (except Nanobiotechnology)

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance

Alerts

News

Iran's Houthi Allies Lie in Wait on Another Key Oil Route: the Red Sea

HKIT Investors Have Opportunity to Join Hitek Global Inc. Fraud Investigation with the Schall Law Firm

Is This Stock a Buy on the Dip?

ROSEN, A LEADING LAW FIRM, Encourages ODDITY Tech Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ODD

High-Flying Biotech Stock Up 360% Faces $48 Million Trim but Remains This Fund's Largest Holding

Bristow Group's CFO Just Sold $1.2 Million in Stock — But Is That the Whole Equation?

ROSEN, A LEADING NATIONAL FIRM, Encourages Alight, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ALIT

ROSEN, A HIGHLY RANKED LAW FIRM, Encourages Hub Group, Inc. Investors to Inquire About Securities Class Action Investigation - HUBG

Uber's Advertising Business May Be Bigger Than Investors Think

This Fund Just Cut a Viridian Stock Position by Over $80 Million. Here's What Investors Should Know

CIGL Investors Have Opportunity to Lead Concorde International Group Ltd. Securities Fraud Lawsuit with the Schall Law Firm

This Biotech Stock Up 135% Just Faced a $44 Million Trim. Here's What Investors Should Know

This Nuclear Energy Trend Could Be Bigger Than Investors Think in 2026

Before Retiring, Warren Buffett Left Investors With a $373 Billion Warning. Here's What History Says the Stock Market Will Do Next.

Biotech Stock Up 72% Sees $8 Million Sale, but Here's Why One Fund Still Seems Bullish

METC DEADLINE ALERT: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Ramaco Resources, Inc. Investors to Secure Counsel Before Important March 31 Deadline in Securities Class Action - METC

XPOF Investors Have Opportunity to Join Xponential Fitness, Inc. Fraud Investigation with the Schall Law Firm

Is Berkshire Hathaway Stock a Buy Right Now?

CIGL Investors Have Opportunity to Lead Concorde International Group Ltd. Securities Fraud Lawsuit

DAFNA Capital Trims iShares Biotechnology ETF Within Broader Biotech Portfolio, According to Recent SEC Filing

About